Company
United StatesPublic company, NASDAQ: LINLinde Inc. (NASDAQ: LIN), Loveland, CO – FDA Inspections
Inspection records and compliance data for Linde Inc. in Loveland, Colorado. 1 FDA inspection on record, last inspected November 07, 2013. Publicly traded as NASDAQ: LIN.
Company Profile
This profile covers Linde Inc. based in Loveland, Colorado, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected November 7, 2013.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 7, 2013 | NAI | Human Drugs · Drug Quality Assurance | 857241 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Linde Inc.
Stock ticker
LIN
Exchange
NASDAQ
Share price
$521.47
Market cap
$239.4B
Price as of
November 6, 2026
FEI Number
1720513
Address
950 Des Moines Ave, Loveland, Colorado 80537, United States
Country
United States
ID: 6f34e70a-ec8a-4b64-9bda-21b3c0e1c1d7